{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T08:33:21Z","timestamp":1657096401337},"reference-count":9,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1016\/j.transproceed.2005.02.007","type":"journal-article","created":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T07:08:52Z","timestamp":1114931332000},"page":"1435-1437","source":"Crossref","is-referenced-by-count":2,"title":["Basiliximab (Simulect) in Renal Transplantation With High Risk for Delayed Graft Function"],"prefix":"10.1016","volume":"37","author":[{"given":"C.","family":"Fernandez Rivera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Alonso Hernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Villaverde Verdejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Oliver Garc\u0131\u0301a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Vald\u00e9s Ca\u00f1edo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2005.02.007_bib1","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1097\/00007890-199812270-00022","article-title":"Deleterious effects of delayed graft function in cadaveric renal transplant recipients independent of acute rejection","volume":"66","author":"Shoskes","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2005.02.007_bib2","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1097\/00007890-200105150-00025","article-title":"A calcineurin antagonist-free induction strategy for immunosuppression in cadaveric kidney transplant recipient at risk for delayed graft function","volume":"71","author":"Hong","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2005.02.007_bib3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00007890-199801270-00013","article-title":"Delayed graft function after renal transplantation","volume":"65","author":"Pfaff","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2005.02.007_bib4","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00007890-199901270-00016","article-title":"Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody","volume":"67","author":"Kahan","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2005.02.007_bib5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00007890-200301150-00007","article-title":"Randomized double-blind study of immunoprophylaxis with basiliximab, in combination with mycofenolate-mofetil\u2013containing triple therapy in renal transplantation","volume":"75","author":"Lawen","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2005.02.007_bib6","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.2165\/00003495-200363240-00009","article-title":"Basiliximab: a review of its use as induction therapy in renal transplantation","volume":"63","author":"Chapman","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.transproceed.2005.02.007_bib7","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/S0041-1345(03)00379-8","article-title":"Calcineurin-free protocols with basiliximab induction allow patients included in \u201cold to old\u201d programs achieve standard kidney transplant function","volume":"35","author":"Emparan","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2005.02.007_bib8","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/01.TP.0000109643.32659.C4","article-title":"Interleukin 2 receptor antagonists for renal transplant recipients: a meta-analysis of randomized trials","volume":"77","author":"Webster","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2005.02.007_bib9","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1034\/j.1600-6143.2003.00010.x","article-title":"Diabetes mellitus after kidney transplantation in United States","volume":"3","author":"Kasiske","year":"2003","journal-title":"Am J Transplant"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134505001211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134505001211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,26]],"date-time":"2019-01-26T15:00:06Z","timestamp":1548514806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134505001211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S0041134505001211"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2005.02.007","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}